Elevance Health, Inc. (VIE:ELV)
Austria · Delayed Price · Currency is EUR 250.20
+0.30 (0.12%)
At close: Mar 4, 2026
Elevance Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,661 | 5,971 | 5,991 | 5,888 | 6,149 |
Depreciation & Amortization | 1,745 | 1,546 | 1,393 | 1,675 | 1,302 |
Stock-Based Compensation | 276 | 191 | 289 | 264 | 255 |
Other Adjustments | 84 | -28 | 571 | 149 | -465 |
Change in Receivables | -2,526 | -683 | -1,762 | -2,510 | -2,138 |
Changes in Accounts Payable | -720 | -272 | 1,640 | 824 | 719 |
Changes in Income Taxes Payable | -297 | 404 | -103 | -338 | 140 |
Changes in Unearned Revenue | -15 | -113 | 290 | -42 | -113 |
Changes in Other Operating Activities | 1,105 | -2,554 | 75 | 2,489 | 2,515 |
Operating Cash Flow | 4,290 | 5,808 | 8,061 | 8,399 | 8,364 |
Operating Cash Flow Growth | -26.14% | -27.95% | -4.02% | 0.42% | -21.74% |
Capital Expenditures | -1,116 | -1,256 | -1,296 | -1,152 | -1,087 |
Purchases of Investments | -15,026 | -17,986 | -16,236 | -24,946 | -18,669 |
Proceeds from Sale of Investments | 15,095 | 18,572 | 13,536 | 22,608 | 14,613 |
Payments for Business Acquisitions | 88 | -4,809 | -1,552 | -649 | -3,476 |
Proceeds from Business Divestments | - | 363 | - | - | - |
Other Investing Activities | -509 | -29 | 78 | -421 | -1,019 |
Investing Cash Flow | -1,344 | -5,167 | -5,572 | -4,560 | -9,638 |
Short-Term Debt Issued | 1,505 | 275 | 225 | 1,365 | 1,375 |
Short-Term Debt Repaid | -1,720 | -135 | -265 | -1,675 | -1,050 |
Net Short-Term Debt Issued (Repaid) | -215 | 140 | -40 | -310 | 325 |
Long-Term Debt Issued | 2,991 | 7,710 | 2,574 | 3,071 | 3,462 |
Long-Term Debt Repaid | -2,147 | -1,650 | -1,909 | -1,899 | -1,068 |
Net Long-Term Debt Issued (Repaid) | 844 | 6,060 | 665 | 1,172 | 2,394 |
Issuance of Common Stock | 79 | 221 | 152 | 182 | 203 |
Repurchase of Common Stock | -2,605 | -2,900 | -2,676 | -2,316 | -1,900 |
Net Common Stock Issued (Repurchased) | -2,526 | -2,679 | -2,524 | -2,134 | -1,697 |
Common Dividends Paid | -1,529 | -1,508 | -1,395 | -1,229 | -1,104 |
Other Financing Activities | 1,688 | -820 | -55 | 1,183 | 505 |
Financing Cash Flow | -1,738 | 1,193 | -3,349 | -1,318 | 423 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -5 | -6 | -1 | -14 | -10 |
Net Cash Flow | 1,203 | 1,828 | -861 | 2,507 | -861 |
Free Cash Flow | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 |
Free Cash Flow Growth | -30.27% | -32.71% | -6.65% | -0.41% | -24.72% |
FCF Margin | 1.61% | 2.60% | 3.97% | 4.66% | 5.31% |
Free Cash Flow Per Share | 14.13 | 19.54 | 28.50 | 29.85 | 29.49 |
Levered Free Cash Flow | 6,993 | 9,935 | 8,611 | 10,212 | 12,353 |
Unlevered Free Cash Flow | -11,458 | -11,872 | -7,687 | -4,434 | -3,292 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.